Pharmacology, Toxicology and Pharmaceutical Science
Opiate
100%
Buprenorphine
64%
Human
45%
Disease
30%
Cocaine
30%
Drug
28%
Toxic Injury
22%
Naloxone
22%
Methadone
21%
Placebo
20%
Opioid Overdose
20%
Oxycodone
20%
Pharmacodynamics
17%
Pharmacokinetics
16%
Blindness
15%
Hydromorphone
13%
Randomized Clinical Trial
13%
Buprenorphine Plus Naloxone
12%
Emergency
11%
Death
11%
Opiate Agonist
10%
Opiate Addiction
10%
Clinical Trial
10%
Combination Therapy
10%
Drug Dependence
9%
Subjective Effects
8%
Duragesic
8%
Naltrexone
7%
Tramadol
7%
Addiction
6%
Analgesic Agent
6%
Pain
5%
Levacetylmethadol
5%
Cannabis
5%
Mortality
5%
Pandemic
5%
Clinical Pharmacology
5%
Tablet
5%
Medicine and Dentistry
Buprenorphine
35%
Opioid Abuse
32%
Opiate
30%
Therapeutic Procedure
28%
Drug Therapy
16%
Patient
12%
Intoxication
11%
Randomized Clinical Trial
8%
Emergency Department
8%
Analysis
8%
Naloxone
8%
Evaluation
8%
Combination Therapy
7%
Clinical Trial
6%
Addictive Behavior
6%
Injection
6%
Physician
6%
COVID-19
6%
Buprenorphine Plus Naloxone
6%
Human
6%
Medicaid
6%
Placebo
6%
Telemedicine
5%
Outpatient
5%
Methadone
5%
Social Sciences
Community Study
18%
Opioid Abuse
9%
Evidence-Based
7%
State
7%
Communities
5%
COVID-19
5%
Medication
5%
Implementation
5%
